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INTRODUCTION
Th e increasing reliance by physicians on endoscopy and the appreciation by the general public that upper endoscopy (EGD) is useful for diagnosis, surveillance, or exclusion of important gastroduodenal diseases have led to an increasing demand for open-access endoscopy ( 1 ) . To optimize the use of fi nite resources in an open-access system, the appropriate selection of patients for EGD is crucial ( 2, 3 ) .
For this purpose, offi cial guidelines for the appropriate use of EGD have been proposed by the American Society for ENDOSCOPY Buri et al.
Gastrointestinal Endoscopy (ASGE) and by EPAGE (European Panel on the appropriateness of Gastrointestinal Endoscopy) ( 2, 4 ) . Observational studies have shown a substantial rate of inappropriate EGD indications, which in turn has been associated with a lower diagnostic yield for relevant fi ndings ( 5 -13 ) . However, the validity of these expert-derived guidelines has never been tested in a randomized study or compared with alternative strategies ( 14 ) .
A more empirical approach to select patients for EGD is to build up predictive rules on the basis of multivariate statistical methods, with previous studies producing confl icting results ( 15, 16 ) . Alternatively, a very simple prediction rule based on the association between alarm features or age ≥ 45 years and the detection of relevant fi ndings, in particular cancer, has been successfully implemented in patients with dyspepsia ( 17, 18 ) . However, its accuracy in selecting nondyspeptic patients for EGD is largely unknown.
Recently, artifi cial neural networks (ANNs) have been developed to predict clinical outcomes with a higher degree of accuracy as compared with multivariate models. ANN has been shown to be eff ective in predicting upper and lower gastrointestinal (GI) bleeding ( 19, 20 ) .
Th e aim of this study was to compare all these diff erent available options to select patients for EGD examinations referred to openaccess Endoscopy Units.
METHODS
A cross-sectional, prospective, multicenter study involving 56 open-access Endoscopy Units, uniformly distributed throughout Italy (SIED Appropriateness Project) was conducted between October 2007 and February 2008. A local study coordinator assumed responsibility for each center, and all clinical investigators were experienced endoscopists (with more than 15 years experience with standard methods). According to the protocol, all patients referred to the participating centers for open-access EGD during 1 month were prospectively enrolled. EGDs were performed according to predefi ned weekly schedules, the referring physicians being unaware of the purpose of the study. All patients gave written informed consent for endoscopy. Data were collected uniformly according to a previously defi ned protocol that included the following four steps: (i) patient evaluation including personal medical history. Th e following variables were systematically collected: age and sex; presenting symptoms (such as dyspepsia, refl ux, atypical refl ux manifestations, anemia, weight loss, dysphagia, vomiting, GI bleeding, family history of gastric cancer); preprocedure endoscopic diagnosis (previous EGD); concomitant therapy (proton pump inhibitors, other antisecretory / antiacid drugs, nonsteroidal anti-infl ammatory drugs / anti-cyclooxygenase-2 / aspirin); (ii) determination of the indication category specifi ed by the ASGE guidelines, on the basis of the information provided by both the patient and the referring physician; type of specialty practiced by the referring physician (primary care physicians, gastroenterologists or other specialists); (iii) performance of EGD; and (iv) reporting of the endoscopic fi ndings, including selection of a standard diagnosis from a predefi ned list. Th e initial two steps were performed by an investigating gastroenterologist before endoscopy. Endoscopic fi ndings were reported with internationally accepted terminology and defi nitions. Data quality assurance was assessed by a random review of 5 % of the procedures.
We selected the following two types of endoscopic lesions at EGD as the main outcomes of the study: (i) relevant fi nding (any fi nding that directly aff ects therapeutic decisions and prognosis, as listed in Appendix A ) ( 5 -12 ) and (ii) new diagnosis of malignancy (cancer or lymphoma). When there was more than one endoscopic diagnosis, the most severe diagnosis was adopted. Histology was required to confi rm all malignancies. Although this was an endoscopic study, in which the centers were not directly involved in cancer treatment, a postendoscopic follow-up was attempted for all the new cases of malignancy. Postsurgical staging was required in the operated patients.
According to the study design, the accuracy of the following clinical and predictive rules were compared:
1. Appropriateness of the indication : Th e ASGE guidelines were used to assess the appropriateness of each examination before the procedure ( 4 ) . Referrals for EGDs were classifi ed into those " generally indicated " (appropriate) and those " generally not indicated " (inappropriate). 2. Simplifi ed predictive rule : According to this option, all EGDs performed in patients ≥ 45 years and / or in those with at least one alarm symptom (dysphagia, weight loss, anemia, GI bleeding, vomiting), or a family history of gastric cancer were considered to be indicated, whereas those performed in patients < 45 years without alarm features were classifi ed as not indicated. 3. Predictive model (logistic regression analysis) : Stepwise multiple logistic regression analysis was used to identify signifi cant predictor variables for each of the considered outcomes. Th e prediction model was built using SPSS version 15.0 (M.J. Norusis, Chicago, IL) stepwise logistic regression analysis on the exploratory sample population with an entry criterion of P < 0.3. Th e stepwise procedure added the independent variables to the model one at a time. In the fi nal model, variables were removed if the retention criterion of P < 0.05 was not met. Th e study population was randomly divided into an exploration group and a validation group. A total of 20 predictor demographic and clinical variables were included in the building process. Once the model was established using the exploratory group, parameter estimates were applied to the validation group to test the predictive accuracy of the model. Each of the two outcomes (relevant fi nding and new malignancy) served as the reference standard for determining the accuracy of the diff erent strategies. In particular, if a relevant endoscopic fi nding or a new malignancy was detected and the EGD was classifi ed as indicated according to one of the four strategies (i.e., " generally indicated " by the ASGE guidelines), the EGD was considered to be a true positive. If the EGD was classifi ed as indicated but no relevant fi nding or new malignancy was diagnosed, the EGD was considered a false-positive result.
We estimated the sensitivity, specifi city, and positive and negative predictive values with 95 % confi dence intervals for each strategy. Areas under the receiver-operating characteristic curves (AUCs) were calculated and compared for clinical and statistical rules with a nonparametric approach using a paired design ( 22 ) . Odds ratio was used for the association between study variables and the selected outcome. Chi-squared test was used to assess the statistical signifi cance of diff erences among proportions. All P values involve hypothesis tests against a two-sided alternative. Diff erences were considered signifi cant at a 5 % probability level. We also reported in Appendix C , the distribution of clinical features in the discordant pairs of predictions (i.e., indicated for the ASGE guidelines and not indicated according to the logistic regression model) among the diff erent strategies to identify areas of main uncertainty.
RESULTS
A cohort of 8,252 (men: 47 % ; mean age: 57 years, range 18 -99 years) patients was enrolled. Primary care physicians, gastroenterologists, and other specialties were the referring physicians in 4,704 (57 % ), 1,402 (17 % ) , and 2,146 (26 % ) cases, respectively. Overall, 6,106 (74 % ) were outpatients, the remaining being hospitalized. Study EGD was the fi rst endoscopy in 5,364 (65 % ) patients, being a control EGD in the remaining 2,888 cases. In the previous EGD, 1,591 patients (55 % ) had a previously relevant endoscopic diagnosis.
A main clinical symptom / sign was reported in 7,104 (86 % ) cases ( Table 1 ). In detail, an alarm feature was present in 2,236 (27 % ) cases, anemia, dysphagia, weight loss, GI bleeding, a family history Portal hypertension assessment 324 (4) Suspicion at RX 73 (1) Operative endoscopy 121 (1) Follow-up benign / precancerous / malignant 381 (5) Duodenal biopsy 166 (2) EGD for other medical / surgical conditions 74 (1) Cancer of unknown origin 10 (0. In 695 (35 % ) patients, alarm symptoms (anemia, dysphagia, weight loss, GI bleeding, vomiting), or a family history of gastric cancer were reported to be associated with dyspepsia, refl ux, or vomiting. In other cases, it was the only symptom reported. Table 1 . Concomitant therapy with proton pump inhibitor was reported by 2,626 (32 % ) patients, other antisecretory / antiacids being used by 948 (11 % ). Concomitant therapy with nonsteroidal anti-infl ammatory drug / anti-cyclooxygenase-2 / aspirin was reported in 719 (9 % ) cases. As shown in Table 2 , detection of relevant fi ndings was reported in 3,803 (46 % ) patients. Malignancy (cancer or lymphoma) was diagnosed in 215 (2.6 % ) cases ( Table 2 ). It was a new diagnosis in 132 (1.6 % ) patients (130 cancers and 2 gastric lymphomas), whereas it was an already diagnosed malignancy (excluded from further analysis) in 83 (0.9 % ) patients. Th e mean age of those with a new malignancy was 71 years (range: 38 -96 years), 76 (57 % ) of them being men. Postendoscopic follow-up was available for 80 (61 % ) patients, and is reported in Table 3 .
Accuracy of appropriateness guidelines
EGD indication was included in the ASGE guidelines in 7,983 (97 % ) patients, the remaining 269 cases being excluded from further analysis within this strategy. EGD indication was classifi ed as appropriate according to the ASGE criteria in 6,389 (80 % ) patients, being inappropriate in the remaining 1,594.
Th e mean sensitivity and specifi city of appropriateness guidelines for the detection of relevant fi ndings were 88 and 27 % , respectively, and the AUC was 0.55. Positive and negative predictive values were 51 and 72 % , respectively.
Mean sensitivity, specifi city, and AUC for the detection of new cases of malignancy were 98 % , 20 % , and 0.58, respectively. Positive and negative predictive values were 2 and 99.8, respectively.
Of the three patients with an inappropriate indication diagnosed with a malignancy, the inappropriateness was referred to atrophic gastritis surveillance (one patient with gastric cancer, 48 years, T3 N1 M0), metastatic cancer of unknown origin (one patient with gastric cancer, 50 years, T4 N1 M1), and symptoms considered Mean sensitivity, specifi city, and AUC for the detection of new cases of malignancy were 97 % , 22 % , and 0.58, respectively. Positive and negative predictive values were 2 and 99.8 % , respectively. Sensitivity and specifi city in dyspeptic and nondyspeptic patients (excluding patients with alarm symptoms) were 81 % (95 % CI: 64, 98) and 33 % (95 % CI: 32, 35), and 100 % (95 % CI: 100, 100) and 27 % (95 % CI: 25, 28), respectively. Four patients < 45 years without alarm symptoms were diagnosed with a new malignancy. One of them (41 years of age), complaining of dyspepsia with refl ux resistant to empiric proton pump inhibitor therapy, was diagnosed with a gastric lymphoma. Th e remaining three, all complaining of dyspepsia resistant to empiric treatment, were diagnosed with gastric cancer at 41 (T2 N1 M0), 43 (T1 N1 M0), and 44 years of age (T1 N1 M0), respectively.
Accuracy of the logistic regression model
Th e association between each of the included variables and the selected endoscopic outcomes at univariate and multivariate analyses are shown in Tables 4 and 5 . functional in a 51-year-old patient complaining of dyspepsia in the previous month, eventually diagnosed with gastric cancer (T3 N3 M0) at EGD.
Accuracy of the simplifi ed predictive rule
When coupling the 6,027 (73 % ) patients ≥ 45 years with the 2,236 patients presenting with an alarm symptom or a family history of gastric cancer, EGD appeared to be indicated in 6,422 (78 % ) patients.
Mean sensitivity, specifi city, and AUC for the detection of relevant fi ndings were 82 % , 26 % , and 0.52, respectively. Positive and negative predictive values were 49 and 63 % , respectively. Sensitivity and specifi city in dyspeptic and nondyspeptic patients (excluding patients with alarm features) were 72 % (95 % confi dence interval (95 % CI): 70, 75) and 37 % (95 % CI: 35, 39), and 76 % (95 % CI: 74, 79) and 29 % (95 % CI: 26, 31), respectively. Mean sensitivity, specifi city, and AUC of the logistic regression model for the detection of relevant fi ndings were 53 % , 74 % , and 0.69, respectively. Positive and negative predictive values were 64 and 64 % , respectively.
Mean sensitivity, specifi city, and AUC for the detection of new cases of malignancy were 60 % , 89 % , and 0.82, respectively. Positive and negative predictive values were 9 and 99 % , respectively.
Accuracy of the ANN model
Th e following variables were selected from the ANN algorithm for the prediction of relevant fi ndings: age ≥ 45 years, sex, alarm symptoms, in-patient setting, typical and atypical refl ux, and the presence of relevant fi ndings at previous EGD.
Estimates of ANN sensitivity, specifi city, and AUC for relevant fi ndings were 84 % , 36 % , and 0.66, respectively. Positive and negative predictive values were 54 and 72 % , respectively.
Th e following variables were selected for the prediction of new malignancy: age ≥ 45 years, weight loss, dysphagia, GI bleeding, vomiting, refl ux, use of nonsteroidal anti-infl ammatory drugs / anti-cyclooxygenase-2 / aspirin, and the presence of relevant fi ndings at previous EGD.
Estimates of ANN sensitivity, specifi city, and the AUC for new malignancy were 83 % , 82 % , and 0.87, respectively. Positive and negative predictive values were 7 and 99.6 % , respectively.
Comparison among the different strategies
As shown in Table 6 and Figure 1 , there was no statistically signifi cant diff erence in accuracy (AUC values) for both relevant fi ndings and new malignancy between the ASGE criteria and the simplifi ed rule (age ≥ 45 / alarm symptoms), whereas both of them were less accurate than the logistic regression and the ANN models for both relevant fi ndings and cancer detection. Th e ANN model also seemed to be statistically signifi cantly more accurate than the logistic regression model for new malignancy, whereas the logistic regression model was more accurate than the ANN model for relevant fi ndings.
DISCUSSION
Our study shows that a simple prediction rule based on age and alarm features is as accurate as the ASGE guidelines in selecting patients for EGD. It is noted that this is true not only for benign relevant fi ndings but also for new cases of malignancy. Th e validity of this approach is indirectly confi rmed by the selection of age and most of the alarm features as independent predictors at both multivariate and ANN analyses. It could be argued that dyspepsia is the most frequent indication for EGD, and that the accuracy of age and alarm features has already been widely described in dyspeptic patients (i.e., Maastricht criteria) ( 18 ) . However, we have shown that such accuracy is similar in both dyspeptic and nondyspeptic patients, most of the latter presenting with refl ux, suggesting the possibility of using a simplifi ed rule also in nondyspeptic patients. Th is is clearly related to the intimate association between older age and a higher risk of cancer, which is independent from the clinical presentation of the upper GI symptoms ( 18, 23 ) .
It seems to be clinically relevant to off er a simple alternative to the ASGE guidelines. Such guidelines are quite complex, consisting of 9 general indications and more than 20 specifi c indications We also reported the rate of EGDs classifi ed as indicated (true + false positives) for each strategy and the number of EGD to be performed to detect 1 fi nding (NNT), to provide an estimate of the endoscopic workload. * P < 0.05 as compared with the ASGE guidelines and age 45 years / alarm features. ** P < 0.05 as compared with all the other strategies.
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Appropriate Selection of Patients for EGD in this setting, so that the positive predictive value is still close to 50 % . For this reason, the substantial improvement in specifi city achieved by logistic regression and ANN models only marginally increases the positive predictive value. Th e simplifi ed clinical rule seemed to have a very high sensitivity for malignancy, so that its negative predictive value was practically equal to that of the other options. In detail, one case of cancer would be detected for every 50 EGDs performed in patients ≥ 45 years or with alarm features, whereas 457 EGDs in patients < 45 years without alarm features would have been required to detect one cancer. Moreover, to detect a cancer does not necessarily correlate with saving a life. Our data on the stage of presentation of gastroesophageal cancers were very dismal. Only one-third of the patients underwent a surgery with curative intent, and < 10 % had a cancer in a localized stage. Th is would mean that more than 5,700 EGDs in patients < 45 years without alarm symptoms would be required to detect one cancer in a localized stage. Moreover, none of the patients < 45 years without any alarm symptoms were found to have a cancer in a localized disease in our series. It could be argued that no cancer in patients < 45 years would have been missed if we had considered as indicated all the initial EGDs performed in those without alarm symptoms and the successive endoscopies in those with a previous relevant endoscopic fi nding. However, in this case only 3 % of all the study EGDs would have been considered as " not indicated, " such a marginal rate questioning on the usefulness of a widespread implementation of a clinical strategy. Diff erent from relevant fi ndings, the higher specifi city of both logistic regression and ANN models substantially aff ected the positive predictive value, because of the low prevalence of malignancy. In detail, these models identifi ed a relatively small subgroup of population -between 12 and 19 % of all the population -at higher risk for malignancy that may need a prioritized EGD.
Despite the high accuracy of malignancy for both clinical strategies and predictive models, it could be argued that a few cancers would be ineludibly missed when adopting any of these strategies to select access to EGD. Conversely, such malignant lesions would be detected when performing an initial endoscopic examination of any patient independently of the presenting complaint. Ultimately, it is an individual decision of any health system whether to adopt or not adopt any fi lter to select access for EGD, as well as for any other medical procedure. Th e rationale behind adopting a fi lter is that the resources saved by not performing the inappropriate procedures may be shift ed in a more eff ective and effi cient manner to other medical procedures in which a higher diagnostic yield is expected because of the appropriateness of the indication ( 13 ) .
Th e main limitation of our study was that we did not randomize patients according to the ASGE criteria and the simplifi ed prediction rule. However, it is unlikely that systematic bias could have altered the collection of the patient age and the presence of alarm symptoms.
In conclusion, our study showed that a simple rule based on age and alarm features may be as accurate as the more complex ASGE guidelines in predicting endoscopic outcome in an unselected EGD population. Regression and ANN models may be useful to prioritize patients at higher risk of malignancy. ( 4 ) . It is noted that only a minority of the EGDs in our study -i.e., 17 % -were prescribed by gastroenterologists, showing that, aft er the implementation of an open-access system, most of the referrals come from primary care physicians or other specialists. A simple prediction rule based on age and alarm features would seem more suitable to non-GI physicians as compared with the more complex ASGE guidelines.
It could be argued that although we confi rmed the high sensitivity of the ASGE guidelines for both relevant fi ndings and cancer, both the simplifi ed rule and the ASGE criteria seemed to be hampered by low specifi city. However, the relatively high prevalence of relevant endoscopic fi ndings reduces the importance of specifi city 
Preprocessing methods and experimental protocols
Data preprocessing was performed using two diff erent resampling criteria of the global dataset.
Random criterion :
We used the so-called 5 × 2 cross-validation protocol (1) . In this procedure, the study sample is randomly divided five times into two subsamples, always different but containing similar distribution of cases and controls: the training subsample (containing the dependent variable) and the testing subsample. During the training phase, ANNs learn a model of data distribution and then, on the basis of such a model, classify subjects in the testing set in a blind manner. Training and testing sets are then reversed, and consequently 10 analyses for every model used are conducted.
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Optimized criterion: training with input selection and testing system
The training with input selection and testing system consists an ensemble of two previously described systems: T & T and IS (2). The T & T system is a robust data resampling technique that arranges the source sample into subsamples that all possess a similar probability density function. In this way, data are split into two or more subsamples to train, test, and validate the ANN models more effectively. The IS system is an evolutionary wrapper system that reduces the amount of data while conserving the largest amount of information available in the data set. The combined action of these two systems allows us to solve two frequent problems in managing ANNs. Both systems are based on a Genetic Algorithm, the Genetic Doping Algorithm (GenD) developed at the Semeion Research Centre (3). After this processing, the features that were most significant
